Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

身体検査 身体検査

Binu V John, Smitha Mary Thomas

    Lancet (London, England)
    |December 20, 2003
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Clinical Features and Outcomes of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease With Increased Alcohol Intake.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
    Same author

    Alpha-1 Antitrypsin Deficiency in Patients With Cirrhosis in a US National Cohort.

    Clinical and translational gastroenterology·2026
    Same author

    Hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease with increased alcohol intake (MetALD).

    JHEP reports : innovation in hepatology·2026
    Same author

    AGA Clinical Practice Update on the Management of Ascites, Volume Overload, and Hyponatremia in Cirrhosis: Expert Review.

    Gastroenterology·2025
    Same author

    Reply: Assessing HCC incidence and surveillance thresholds in non-cirrhotic MASLD.

    Hepatology (Baltimore, Md.)·2025
    Same author

    Reply: Are we overestimating LSM-based HCC risk in MASLD? Addressing immortal time bias.

    Hepatology (Baltimore, Md.)·2025
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る